Published by Josh White on 22nd September 2023
(Sharecast News) - New high-level results from AstraZeneca's TROPION-Breast01 phase three trial, released on Friday, carried encouraging news for patients with inoperable or metastatic hormone receptor (HR)-positive, HER2-low or negative breast cancer.
URL: http://www.digitallook.com/dl/news/story/33788411/...